ABSTRACT: Seven new carolignans, including two pairs of enantiomers (±)-erythro-7′-methylcarolignan E (1a/1b) and (±)-threo-7′-methylcarolignan E (2a/2b), (+)-threo-carolignan E (3a), (+)-erythro-carolignan E (4a), and (−)-erythrocarolignan Z (5), together with four known lignans (3b, 4b, 6, and 7) and six polyphenols (8−13) were isolated from the aerial parts of Euphorbia sikkimensis. The structures of the new compounds were elucidated by spectroscopic analysis, and their absolute configurations were determined by electronic circular dichroism calculations. Seven of the isolates were examined for anti-HIV effects, and compounds 1a and 1b showed moderate anti-HIV activity with EC 50 values of 6.3 and 5.3 μM.
T he genus Euphorbia belongs to the family Euphorbiaceae, which is characterized by production of a white, milky latex that is somewhat toxic. The family contains about 300 genera and 7000 species. Euphorbia is one of the largest genera in the Euphorbiaceae family, with about 1600 species. Numerous chemical studies on the Euphorbia genus have been performed. 1, 2 Euphorbia sikkimensis Boiss. has been used to treat poisoning, malaria, rheumatism, and jaundice. 3 In 2013, new and known diterpenes, triterpenoids, tocopherol derivatives, and other compounds were isolated. 4, 5 Two diterpenoids showed antiproliferative effects against the A549 cancer cell line, while (−)-bornyl ferulate exhibited antiangiogenic activity in a zebrafish model. 5 In a continuing search for anti-HIV natural products from herbal medicinal plants, anti-HIV screening showed that an EtOAc-soluble fraction from an ethanol extract of the aerial parts of E. sikkimensis had an EC 50 value of 2.5 μg/mL and an SI (selective index) value of more than 8.3. Prior literature reported that diterpenoids from Euphorbia showed potent anti-HIV activity at the nanomolar level, 6, 7 whereas one of these diterpenoids, a phorbol ester, also showed tumor-promoting activity. 8 These results encouraged us to investigate the anti-HIV-active constituents of the EtOAc-soluble fraction, which led to the isolation and characterization of seven new lignans (1−7) and six polyphenols (8−13) . Compounds 1a and 1b showed moderate anti-HIV activity with EC 50 values of 6.3 and 5.3 μM, respectively. Herein are reported details of the isolation, structural elucidation, and anti-HIV activity of these compounds.
The known compounds were identified as (−)-(7′R,8′S)-erythro-carolignan E (3b), 9 ,10 (−)-(7′S,8′S)-threo-carolignan E (4b), 9 ,10 threo-guaiacylglycerol-β-O-4′-dihydroconiferyl alcohol (6), 11, 12 erythro-guaiacylglycerol-β-O-4′-dihydroconiferyl alcohol (7), 11, 12 (E)-ferulic acid (8), 13, 14 ethyl ferulate (9), 14 protocatechuic acid (10), 15, 16 vanillic acid (11), 17, 18 methyl gallate (12) , 19 and ethyl gallate (13) , 19 based on spectroscopic data analysis and comparison with reported literature values.
■ RESULTS AND DISCUSSION
Compound 1 (1a/1b) was obtained as a white, amorphous solid. A molecular formula of C 41 H 44 O 13 was deduced from a quasimolecular ion peak at m/z 743.27039 (calcd 743.27091) observed in the negative HRESIMS. The IR spectrum showed absorption bands for OH (3407 cm (Tables 1 and 2 ) also indicated two 1,3,4-trisubstituted aromatic units (rings B and D) and five methoxy groups. HMBC correlations (Figure 1 ) of H-9″ (δ H 4.15, 2H, t, J = 6.5 Hz) with C-9‴ (δ C 167.5) and H-9′ (δ H 4.11, 1H, dd, J = 4.7, 11.6 Hz; 4.31, 1H, dd, J = 2.8, 11.6 Hz) with C-9 (δ C 167.1) showed that two feruloyl units were connected at C-9 and C-9‴. All of the above data were closely similar to those of the known compound erythro-carolignan E, 9,10 except for an additional methoxy group in the new compound. The position of this methoxy group at C-7′ was confirmed from the HMBC correlation of MeO (δ H 3.27, s) with C-7′ (δ C 83.5, d). Its relative configuration was established on the basis of NOESY correlations ( Figure 2) and interpretation of 1 H− 1 H coupling constants. A coupling constant of 15.9 Hz between H-8 (8‴) and H-7 (7‴) suggested an E-configuration for Δ 7 and Δ 7 ‴. The coupling constant between H-7′ and H-8′ (3.0 Hz) implied an erythroconfiguration of these two protons. 20−22 Thus, compound 1 (erythro-7′-methylcarolignan E) was fully identified.
The specific rotation of 1 approached zero, and no Cotton effect was found in the electronic circular dichroism (ECD) spectrum of 1, indicating a racemic mixture. Subsequent chiral resolution of 1 afforded the anticipated enantiomers 1a and 1b, which showed mirror image-like ECD curves ( Figure 3a 1b, ECD calculations were performed for the two configurations (7′R,8′S)-and (7′S,8′R)-1 using the Gaussian 09 program at the TD-DFT-B3LYP/6-311++G(d,p) level in MeCN. The calculation for the 7′R,8′S enantiomer agreed with the experimental ECD data (Figure 3a ) of 1a. Thus, 1a has a 7′R,8′S-configuration. The calculated ECD spectrum for the 7′S,8′R-configuration was in good accordance with the experimental spectrum of 1b ( Figure 3a) . Consequently, the absolute configuration of 1b was unambiguously assigned with the 7′S,8′R-configuration. Thus, compounds 1a and 1b were given the trivial names (−)-(7′R,8′S)-erythro-7′-methylcarolignan E and (+)-(7′S,8′R)-erythro-7′-methylcarolignan E, respectively. Compound 2 (2a/2b) was isolated as a white, amorphous solid, having the same molecular formula as that of 1 as deduced from HRESIMS. The NMR data of 2 were almost identical to those of 1, except for a slight discrepancy in the positions of the oxygenated methines (C-7′ and C-8′). Detailed 2D NMR analysis (Figures S18−20, Supporting Information) revealed that 2 shares the same planar structure as that of 1, indicating 2 to be a stereoisomer of 1 with the configuration changed at C-7′ or C-8′. A threo-configuration of 2 was further determined by the coupling constants between H-7′ and H-8′ (6.3 Hz). 20, 23 Compound 2 also has negligible optical activity and an ECD spectrum devoid of Cotton effects. Chiral isolation of 2 afforded the enantiomers 2a and 2b. By comparison of the calculated ECD spectra of 7′S,8′S-2 and 7′R,8′R-2 with the experimental data of 2a and 2b (Figure 3b ), the absolute configurations of 2a and 2b were assigned as 7′S,8′S and 7′R,8′R. Compounds 2a and 2b were given the trivial names (−)-(7′S,8′S)-threo-7′-methylcarolignan E and (+)-(7′R,8′R)-threo-7′-methylcarolignan E, respectively.
Compound 3 (3a/3b), obtained as a white, amorphous solid, gave a molecular formula C 40 H 42 O 13 determined from the HRESIMS ion at m/z 729.2542 [M − H]¯(calcd C 40 H 41 O 13 ). Its NMR data (Tables 1 and 2) were almost identical to those of threo-carolignan E. 9, 10 Compound 3 showed a negligible specific rotation and CD spectrum, indicating it to be a racemic mixture. Subsequent chiral separation of 3 afforded a pair of enantiomer 3a and 3b, which had opposite ECD curves ( Figure  3c The absolute configurations of 3a and 3b were determined using the same methods as described in 1a and 1b. Thus, 3a was defined as (+)-(7′R,8′R)-threo-carolignan E, and 3b was identified as the known compound (−)-(7′S,8′S)-threocarolignan E. 10 Compound 4 (4a/4b), a white, amorphous solid, showed the same molecular formula as that of 3. The two compounds had similar NMR data, except for the position of the C-7′ and C-8′ oxygenated methines. Detailed 2D NMR analysis confirmed that 4 and 3 shared the same planar structure, indicating that 4 is a stereoisomer of 3 with a different orientation of the substituents at C-7′ or C-8′. The coupling constant J 7′,8′ was 3.3 Hz, so therefore the relative configuration at C-7′ and C-8′ was erythro. Compound 4 also showed a negligible optical activity and an ECD spectrum devoid of Cotton effects. Chiral isolation of 4 afforded the enantiomers 4a and 4b. By comparison of the calculated ECD spectra of the 7′R,8′S and 7′S,8′R configurations of 4 with the experimental data of 4a and 4b (Figure 
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Article 3d), the absolute configurations of 4a and 4b were assigned as 7′S,8′R and 7′R,8′S, respectively. Thus, 4a was identified as (+)-(7′S,8′R)-erythro-carolignan E, and 4b was elucidated as the known compound (−)-(7′R,8′S)-erythro-carolignan E. erythro-configuration of 5 was further determined by the coupling constants between H-7′ and H-8′ (3.1 Hz). 20−22 The experimental ECD spectrum of 5 showed an ECD curve with Cotton effects around 324 (−), 290 (−), and 242 (+) nm (Figure 3e ). The absolute configuration of 5 was assigned as R,S through comparison with the calculated ECD spectra of (7′R,8′S)-5 ( Figure 3e ). Thus, 5 was elucidated as (−)-7′R,8′S-erythro-carolignan Z.
Seven compounds (1a, 1b, 2a, 2b, 5, 8 , and 9) were tested for in vitro inhibitory effects against HIV-1 replication in MT4 cell lines, with AZT used as the positive control. One pair of enantiomers, 1a and 1b, showed more potent anti-HIV activity.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were measured on a PerkinElmer 341 automatic polarimeter. UV spectra were recorded using a Shimadzu UV-2450 spectrophotometer. CD spectra were obtained on an Applied Photophysics Chirascan spectrometer. IR spectra were determined on a Bruker Tensor 37 infrared spectrophotometer. The 1 H (400 MHz), 13 C (100 MHz), and 2D NMR spectra were obtained on a Bruker AM-400 with tetramethylsilane as an internal reference at 25°C. Chemical shifts (δ) are expressed in ppm with reference to the solvent signals. HRESIMS were acquired on a Shimadzu LCMS-IT-TOF instrument, and the ESIMS data were measured on an Agilent 1200 series LC-MS/ MS system. Macroporous resin D101 (Sinopharm Chemical Reagent Co. Ltd., Shanghai, People's Republic of China), RP-C18 silica gel (Fuji, 40−75 μm), MCI gel CHP20P (75−150 μm, Mitsubishi Chemical Corporation, Tokyo, Japan), silica gel (200−300 mesh, Marine Chemical Ltd., Qingdao, People's Republic of China), and Sephadex LH-20 (GE Healthcare Bio-Sciences AB, Sweden) were used for column chromatography. Analytical and semipreparative HPLC separation were carried out on an LC-20AT Shimadzu liquid chromatography system with a Zorbax SB-C18 column (250 × 9.4 mm, 5 μm) or an Agilent SB-C18 column connected with an SPD-M20A diode array detector. Semipreparative chiral HPLC separation was carried out on an LC-20AT Shimadzu liquid chromatography system with a Phenomenex Lux cellulose-2 chiral-phase column (250 × 10 mm, 5 μm). Thin-layer chromatography (TLC) analysis was carried out on silica gel plates (Marine Chemical Ltd.). Fractions were monitored by TLC and visualized by heating plates sprayed with 5% H 2 SO 4 in EtOH. All solvents were of analytical grade (Guangzhou Chemical Reagents Company Ltd., Guangzhou, People's Republic of China).
Plant Material. The aerial parts of Euphorbia sikkimensis were collected at Longli County of the Qiannan Buyi National Minority Miao National Minority Autonomous Region, Guizhou Province, People's Republic of China, in July 2014. The sample was identified by Dr. Qingwen Sun from Guiyang College of Traditional Chinese Medicine, and a voucher specimen (GZQSY356) has been deposited at the School of Pharmaceutical Science, Sun Yat-sen University.
Extraction and Isolation. The air-dried and powdered aerial parts (20 kg) of E. sikkimensis were extracted with 95% EtOH (3 × 40 L) at room temperature for 48 h. The solvent was concentrated under reduced pressure to give a crude extract (2.562 kg). The 95% EtOH extract was then suspended in H 2 O (2 L) and successively partitioned with petroleum ether (3 × 8 L), EtOAc (3 × 8 L), and n-BuOH (3 × 8 L) to yield three corresponding portions. The EtOAc-soluble extract (334 g) was chromatographed on D101 macroporous resin eluting with a step gradient of EtOH−H 2 O (2:8, 5:5, 7:3, 10:0) to afford four fractions (A−D). Fraction A was separated using MCI gel CHP20P eluting with an increasing gradient of MeOH−H 2 O from 30% to 100% and then further purified by silica gel columns to give compounds 8 (4 mg), 10 (6 mg), 11 (20 mg), 12 (2.0 g), and 13 (5.2 g). Fraction B was subjected to an RP-18 column with MeOH−H 2 O (30−100%) as eluent to afford four subfractions (B1−B4). Fraction B1 (16.4 g) was chromatographed on a silica gel column using CH 2 Cl 2 −MeOH (1:0, 100:1, 15:1) to yield six subfractions (B1a−B1f 
;
1 H NMR (CDCl 3 , 400 MHz) and 13 C NMR (CDCl 3 , 100 MHz) data, see Tables 1 and 2 Multicycle Viral Replication in MT4 Cell Assay. The anti-HIV-1 assay was performed as previously described. 24 HIV-1 NL4-3 Nanolucsec at an infecting dose of 50 TCID 50 /well was used to infect MT4 cells (1 × 10 5 cells/mL) in the presence of compounds at various concentrations in 96-well plates. On day 3 postinfection, supernatant samples were harvested and assayed for luciferase activity using the Promega Nano-Glo luciferase assay system. The antiviral potency is defined as the drug concentration that reduces the luciferase activity by 50% (EC 50 ).
Cytotoxicity Assay. A CytoTox-Glo cytotoxicity assay (Promega) was used to determine the cytotoxicity of the isolates. MT4 cells were cultured in the presence of various concentrations of the compounds for 3 days. Cytotoxicity of the compounds was determined by following the protocol provided by the manufacturer. The 50% cytotoxic concentration (CC 50 ) was defined as the concentration that caused a 50% reduction of cell viability.
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